Edition:
United Kingdom

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

2.92USD
4:12pm GMT
Change (% chg)

$0.01 (+0.34%)
Prev Close
$2.91
Open
$3.06
Day's High
$3.06
Day's Low
$2.86
Volume
565
Avg. Vol
4,349
52-wk High
$9.25
52-wk Low
$2.59

Chart for

About

PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does... (more)

Overall

Beta: --
Market Cap(Mil.): $69.46
Shares Outstanding(Mil.): 13.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome

* PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME

28 Nov 2017

BRIEF-Pavmed reports Q3 adjusted non-GAAP loss per share $0.13

* Q3 adjusted non-GAAP loss per share $0.13 Source text for Eikon: Further company coverage:

15 Nov 2017

BRIEF-Pavmed offers up to 2.7 mln shares

* Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing Source text: http://bit.ly/2iDN6XW Further company coverage:

08 Nov 2017

BRIEF-Pavmed says has received a letter from FDA regarding its portio intraosseous infusion system​

* Pavmed Inc - has received a letter from food and drug administration regarding its portio intraosseous infusion system​

03 Oct 2017

BRIEF-PAVmed files for mixed shelf of up to $75 million

* PAVmed files for mixed shelf of up to $75 million - SEC filing Source text: (http://bit.ly/2hkAgwR) Further company coverage:

21 Sep 2017

BRIEF-Pavmed CEO Lishan Aklog buys 9,100 shares of co's common stock

* Pavmed Inc CEO ‍lishan Aklog reports purchase of 9,100 shares of co's common stock between Aug 23-24 - SEC filing ​ Source text: (http://bit.ly/2vdLcGE) Further company coverage:

25 Aug 2017

Earnings vs. Estimates